Quality-of-life assessment in colorectal cancer patients: Evaluation of cancer therapies

被引:0
作者
Sprangers, MAG [1 ]
机构
[1] Univ Amsterdam, Acad Med Ctr, Dept Med Psychol, NL-1105 AZ Amsterdam, Netherlands
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:691 / 696
页数:6
相关论文
共 46 条
[1]   THE EUROPEAN-ORGANIZATION-FOR-RESEARCH-AND-TREATMENT-OF-CANCER QLQ-C30 - A QUALITY-OF-LIFE INSTRUMENT FOR USE IN INTERNATIONAL CLINICAL-TRIALS IN ONCOLOGY [J].
AARONSON, NK ;
AHMEDZAI, S ;
BERGMAN, B ;
BULLINGER, M ;
CULL, A ;
DUEZ, NJ ;
FILIBERTI, A ;
FLECHTNER, H ;
FLEISHMAN, SB ;
DEHAES, JCJM ;
KAASA, S ;
KLEE, M ;
OSOBA, D ;
RAZAVI, D ;
ROFE, PB ;
SCHRAUB, S ;
SNEEUW, K ;
SULLIVAN, M ;
TAKEDA, F .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (05) :365-376
[2]   QUALITY-OF-LIFE AND SURVIVAL WITH CONTINUOUS HEPATIC-ARTERY FLOXURIDINE INFUSION FOR COLORECTAL LIVER METASTASES [J].
ALLENMERSH, TG ;
EARLAM, S ;
FORDY, C ;
ABRAMS, K ;
HOUGHTON, J .
LANCET, 1994, 344 (8932) :1255-1260
[3]  
*AM CANC SOC, 1991, CANCER S, V67, P765
[4]   THE SICKNESS IMPACT PROFILE - DEVELOPMENT AND FINAL REVISION OF A HEALTH-STATUS MEASURE [J].
BERGNER, M ;
BOBBITT, RA ;
CARTER, WB ;
GILSON, BS .
MEDICAL CARE, 1981, 19 (08) :787-805
[5]  
Cella D F, 1990, Oncology (Williston Park), V4, P29
[6]   THE FUNCTIONAL ASSESSMENT OF CANCER-THERAPY SCALE - DEVELOPMENT AND VALIDATION OF THE GENERAL MEASURE [J].
CELLA, DF ;
TULSKY, DS ;
GRAY, G ;
SARAFIAN, B ;
LINN, E ;
BONOMI, A ;
SILBERMAN, M ;
YELLEN, SB ;
WINICOUR, P ;
BRANNON, J ;
ECKBERG, K ;
LLOYD, S ;
PURL, S ;
BLENDOWSKI, C ;
GOODMAN, M ;
BARNICLE, M ;
STEWART, I ;
MCHALE, M ;
BONOMI, P ;
KAPLAN, E ;
TAYLOR, S ;
THOMAS, CR ;
HARRIS, J .
JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (03) :570-579
[7]   PROGNOSTIC VALUE OF QUALITY-OF-LIFE SCORES DURING CHEMOTHERAPY FOR ADVANCED BREAST-CANCER [J].
COATES, A ;
GEBSKI, V ;
SIGNORINI, D ;
MURRAY, P ;
MCNEIL, D ;
BYRNE, M ;
FORBES, JF .
JOURNAL OF CLINICAL ONCOLOGY, 1992, 10 (12) :1833-1838
[8]   'Tomudex' (ZD1694): Results of a randomised trial in advanced colorectal cancer demonstrate efficacy and reduced mucositis and leucopenia [J].
Cunningham, D ;
Zalcberg, JR ;
Rath, U ;
Olver, I ;
VanCutsem, E ;
Svensson, C ;
Seitz, JF ;
Harper, P ;
Kerr, D ;
PerezManga, G ;
Azab, M ;
Seymour, L ;
Lowery, K ;
Ackland, SP ;
Basser, RL ;
Clarke, SJ ;
Goldstein, D ;
Green, MD ;
Grygiel, JJ ;
McKendrick, JJ ;
Millward, MJ ;
Olver, IN ;
Tattersall, MHN ;
Thomson, DB ;
Jakesz, R ;
Buset, M ;
Tueni, EA ;
VanCutsem, EJD ;
Bauer, J ;
Beska, F ;
Adenis, A ;
Brunet, R ;
Francois, E ;
Paillot, B ;
Rougier, P ;
Fink, UFW ;
Knuth, KRA ;
Koenig, HJ ;
Bohme, MWJ ;
Wander, HE ;
Amadori, D ;
Frassineti, L ;
Cocconi, G ;
Passalacqua, R ;
Frigerio, F ;
Barni, S ;
Luporini, G ;
Labianca, R ;
Marini, G ;
Zaniboni, A .
EUROPEAN JOURNAL OF CANCER, 1995, 31A (12) :1945-1954
[9]   MEASURING PSYCHOLOGICAL AND PHYSICAL DISTRESS IN CANCER-PATIENTS - STRUCTURE AND APPLICATION OF THE ROTTERDAM-SYMPTOM-CHECKLIST [J].
DEHAES, JCJM ;
VANKNIPPENBERG, FCE ;
NEIJT, JP .
BRITISH JOURNAL OF CANCER, 1990, 62 (06) :1034-1038
[10]   Relation between tumor size, quality of life, and survival in patients with colorectal liver metastases [J].
Earlam, S ;
Glover, C ;
Fordy, C ;
Burke, D ;
AllenMersh, TG .
JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (01) :171-175